“SARS-CoV-2 changes and adapts, we must do the same”: Jorge Alcocer on Ómicron’s progress

(Foto: Twitter/SSalud_mx)

Despite the fact that this Friday Mexico registered another new record of COVID-19 infections in the last 24 hours, with 44,293 cases, the Secretary of Health, Jorge Alcocer Varela, assured that after two years the authorities have already learned to monitor and to build necessary actions to fight new variants, like Ómicron (b.1.1.529).

Heading the first meeting of the year of the National Health Council for Well-being (Conasabi) that was held in virtual mode, Alcocer Varela made clear his intention not to impose specific restrictions, since “no limitation to freedom or violation of fundamental human rights is an excuse to confront the virus”, as he pointed out that the main weapons to mitigate Ómicron are “education, prevention and health promotion”.

“The SARS-CoV-2 virus changes and adapts, we must do the same to deal with the pandemic”

However, he asked the health authorities of the 32 states of the country to maintain the hospital reconversion plans and adhere to the guidelines issued by the Ministry of Health.

(Foto: Twitter/SSalud_mx)
(Foto: Twitter/SSalud_mx)

In addition, he celebrated that this October 14, the Federal Commission for the Protection against Sanitary Risks (Cofepris) authorized the drug Paxlovid, from the pharmaceutical company Pfizer, for emergency use to treat adult patients with mild or moderate COVID-19 and at risk of complications. .

For his part, Dr. Hugo López-Gatell, Undersecretary for Prevention and Health Promotion, mentioned that the hospital reconversion process will focus on expanding capacity in emergency rooms and outpatient clinics, because in general, the The omicron variant requires outpatient clinical management.

And it is that the so-called “coronavirus czar” maintained that although Ómicron is more transmissible, “the proportion of serious cases is considerably lower.”

CHRONICLE ACCOMPANIES: MEXICO CORONAVIRUS - MEX2153.  MEXICO CITY (MEXICO) 01/05/2022.- A person takes a test to detect covid-19 today, in Mexico City (Mexico).  After Christmas, Mexicans have once again seen how cases begin to increase uncontrollably.  For many residents of Mexico City, free public health tests are their only option to find out if they are infected.  However, the demand has exceeded the care capacity of health centers.  EFE / Alex Cruz
CHRONICLE ACCOMPANIES: MEXICO CORONAVIRUS – MEX2153. MEXICO CITY (MEXICO) 01/05/2022.- A person takes a test to detect covid-19 today, in Mexico City (Mexico). After Christmas, Mexicans have once again seen how cases begin to increase uncontrollably. For many residents of Mexico City, free public health tests are their only option to find out if they are infected. However, the demand has exceeded the care capacity of health centers. EFE / Alex Cruz

Regarding the shortage of COVID-19 tests, the general director of Health Promotion, Ricardo Cortés Alcalá, recommended a “rational use”, since he said that its application should be privileged in cases of Serious Acute Respiratory Infection (SARI), people with comorbidities, obesity, diabetes and uncontrolled hypertension

Although those who have already been infected in this “fourth wave”, Cortés Alcalá indicated that the time of isolation was reduced to seven days, so that people can resume their usual activities while maintaining basic prevention measures. This is because at least 88% of the adult population in Mexico already has a complete vaccination schedule.

In turn, the general director of the National Center for Preventive Programs and Disease Control (Cenaprece), Ruy López Ridaura, announced the advances in the reinforcement strategy and vaccination modalities.

So far, 54% of older adults have a booster dose, 45% of workers in the health sector and 45 percent in the education sector.

Likewise, 57% of children and adolescents between 15 and 17 years of age and 34% of pregnant women have received the vaccine.

More information in development.



Reference-www.infobae.com

Leave a Reply

Your email address will not be published.